These findings suggest that susceptibility genes that are strongly associated with SLE are also predisposing factors for CLE and that the type I IFN pathway contributes to the pathogenesis of CLE, as TYK2 and IRF5 are involved in the type I IFN pathway. The gene discussed is TYK2; the disease is systemic lupus erythematosus.